| CTRI Number |
CTRI/2025/09/094385 [Registered on: 08/09/2025] Trial Registered Prospectively |
| Last Modified On: |
08/09/2025 |
| Post Graduate Thesis |
No |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug Ayurveda Process of Care Changes |
| Study Design |
Non-randomized, Active Controlled Trial |
|
Public Title of Study
|
Role of Ayurveda gel in Knee joint pain |
|
Scientific Title of Study
|
Effect of Gel Containing Plumbago Zeylanica in Mild to Moderate Knee Osteoarthritis –A Single Armed Open Label Pilot Clinical Trial |
| Trial Acronym |
|
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Pradeep L Grampurohit |
| Designation |
Professor |
| Affiliation |
KAHERs Shri B M K Ayurveda Mahavidyalaya |
| Address |
OPD no 04 and IPD Department of Panchakarma KAHERs Shri B M K Ayurveda Mahavidyalaya Shahapur Belagavi Karnataka
Belgaum KARNATAKA 590003 India |
| Phone |
09964144197 |
| Fax |
|
| Email |
pradeepgrampurohit@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Pradeep L Grampurohit |
| Designation |
Professor |
| Affiliation |
KAHERs Shri B M Kankanawadi Ayurveda Mahavidyalaya |
| Address |
OPD no 04 and IPD Department of Panchakarma KAHERs Shri B M K Ayurveda Mahavidyalaya Shahapur Belagavi Karnataka
Belgaum KARNATAKA 590003 India |
| Phone |
09964144197 |
| Fax |
|
| Email |
pradeepgrampurohit@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Pradeep L Grampurohit |
| Designation |
Professor |
| Affiliation |
KAHERs Shri B M K Ayurveda Mahavidyalaya |
| Address |
OPD no 04 and IPD Department of Panchakarma KAHERs Shri B M K Ayurveda Mahavidyalaya Shahapur Belagavi Karnataka
Belgaum KARNATAKA 590003 India |
| Phone |
09964144197 |
| Fax |
|
| Email |
pradeepgrampurohit@gmail.com |
|
|
Source of Monetary or Material Support
|
| KLE AYURVEDA PHARMACY KHASBAG SHAHAPUR BELGAUM 590003 |
|
|
Primary Sponsor
|
| Name |
ICMR Belgaum |
| Address |
Accounts Department RMRC ICMR Layout, Nehru Nagar, Belagavi, Karnataka 590016. |
| Type of Sponsor |
Government funding agency |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Pradeep L Grampurohit |
KLE Ayurveda Hospital and MRC |
OPD no 04 and IPD Department of Panchakarma KLE Ayurveda Hospital and MRC Shahapur Belagavi Karnataka 590003 Belgaum KARNATAKA |
09964144197
pradeepgrampurohit@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| KAHERS Shri B M Kankanwadi Ayurveda mahavidhyalaay, Belgaum |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition:M170||Bilateral primary osteoarthritis of knee. Ayurveda Condition: SANDHIGATAVATAH, |
|
|
Intervention / Comparator Agent
|
| sno | Intervention/Comparator | Type | Drug-Type | Procedure Name | Details | | 1 | Intervention Arm | Drug | Other than Classical | | (1) Medicine Name: Pulbago Gel, Reference: NA, Route: Topical, Dosage Form: Malahara/ Ointment/ Balm, Dose: 10(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 7 Days, anupAna/sahapAna: No, Additional Information: Twice in a Day for a period of 7days |
|
|
|
Inclusion Criteria
|
| Age From |
30.00 Year(s) |
| Age To |
70.00 Year(s) |
| Gender |
Both |
| Details |
Mild and Moderate cases of knee osteoarthritis
Willing to give consent for participating in the study
Patients who are currently on analgesics NSAID will be given a washout period of 8 days prior to recruitment |
|
| ExclusionCriteria |
| Details |
Patients having severe knee osteoarthritis
Those who are suffering from dermatitis or had a history of dermatitis
Pregnant and lactating women
Any other conditions which in the opinion of investigator will place the subject at risk or will influence the conduct of study or interpretation of results
|
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Pain (VAS) Tenderness Shotha swelling Inflammation Stabdata Stiffness walking velocity |
0th Day. 7th Day |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
Changes in following parameters between day 0day 8 day in CBC, LFT, RFT
|
0 day 8 th day |
|
|
Target Sample Size
|
Total Sample Size="30" Sample Size from India="30"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 2 |
|
Date of First Enrollment (India)
|
10/11/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="2" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Yet Recruiting |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
Effect of Gel Containing Plumbago Zeylanica in Mild to Moderate Knee Osteoarthritis A Single Armed Open Label Pilot Clinical Trial Objectives To evaluate the efficacy of Plumbago zeylanica gel as topical application in mild to moderate Knee Osteoarthritis in pain To assess the safety of Plumbago zeylanica gel as topical application in mild to moderate Knee Osteoarthritis Single centric Single Group clinical conditions having pain and inflammation with Pretest and Posttest design 30 patients with knee osteoarthritis meeting all inclusion/exclusion criteria will be included in the study Trial medication Twice in a Day for a period of 7days Gel Containing Plumbago Zeylanica This will be applied at the site of pain Follow-up will be on 0th & 8th day |